Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.68 |
| ▸ | PARP1 | P09874 | 1/20 | 0.68 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | APEX1 | P27695 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | NPC1 | O15118 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.63 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | PRKAG1 | P54619 | 2/20 | 0.59 |
| ▸ | PRKAA2 | P54646 | 2/20 | 0.59 |
| ▸ | PRKAB1 | Q9Y478 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Procodazole SCHEMBL838841 | 1.00 | CHRM1 (1.00) | CHRM1KDM4EPARP1PARP2CYP1A2 | |
| Procodazole SCHEMBL29404024 | 1.00 | CHRM1 (1.00) | CHRM1KDM4EPARP1PARP2CYP1A2 | |
| Procodazole SCHEMBL5413283 | 0.95 | CHRM1 (0.91) | CHRM1KDM4EPARP1PARP2CYP1A2 | |
| SCHEMBL2017763 | 0.90 | CHRM1 (0.82) | CHRM1KDM4ECYP1A2CYP2C9MAPT | |
| SCHEMBL7433457 | 0.89 | CHRM1 (0.80) | CHRM1KDM4ECYP1A2CYP2C9MAPT | |
| SCHEMBL14565997 | 0.88 | CHRM1 (0.78) | CHRM1KDM4ECYP1A2CYP2C9MAPT | |
| SCHEMBL12999426 | 0.86 | GAA (0.75) | CHRM1KDM4ECYP1A2CYP2C9MAPT | |
| SCHEMBL4573158 | 0.85 | CHRM1 (0.74) | CHRM1KDM4ECYP1A2CYP2C9MAPT | |
| SCHEMBL19368796 | 0.85 | CHRM1 (0.74) | CHRM1KDM4ECYP1A2CYP2C9MAPT | |
| SCHEMBL5717769 | 0.85 | CHRM1 (0.74) | CHRM1KDM4ECYP1A2CYP2C9MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2361 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4602049-A1 | SOS1 INHIBITORS | Bayer Aktiengesellschaft (DE) | 2025-08-20 | — | — | EP | claimed |
| EP-4587439-A1 | SULFONE-SUBSTITUTED PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF CANCER | Bayer Aktiengesellschaft (DE) | 2025-07-23 | — | — | EP | claimed |
| US-20250154170-A1 | FUSED PYRIMIDINES AS KRAS INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2025-05-15 | — | — | US | claimed |
| CN-119894893-A | Sulfone substituted pyrido [3,4-D ] pyrimidine derivatives for the treatment of cancer | 拜耳公司 | 2025-04-25 | — | — | CN | claimed |
| WO-2025021997-A1 | NEW MAP4K1 INHIBITORS | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2025-01-30 | — | — | WO | claimed |
| WO-2025016899-A1 | SPIROCYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER | BAYER AKTIENGESELLSCHAFT (DE) | 2025-01-23 | — | — | WO | claimed |
| EP-4476221-A1 | FUSED PYRIMIDINES AS KRAS INHIBITORS | Bayer Aktiengesellschaft (DE) | 2024-12-18 | — | — | EP | claimed |
| WO-2024188937-A1 | COMBINATIONS OF ATR KINASE INHIBITORS AND PARP INHIBITORS TO TREAT HYPER-PROLIFERATIVE CONDITIONS E.G. CANCER | BAYER AKTIENGESELLSCHAFT (DE) | 2024-09-19 | — | — | WO | claimed |
| US-20240247015-A1 | PHOSPHORUS DERIVATIVES AS NOVEL SOS1 INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2024-07-25 | — | — | US | claimed |
| WO-2024079252-A1 | SOS1 INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2024-04-18 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| US-6110953-A | Pharmaceutical composition for inhibiting the growth of cancers | THE PROCTER & GAMBLE COMPANY (US) | 2000-08-29 | — | — | US | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-6090796-A | Pharmaceutical composition for inhibiting the growth of cancers | THE PROCTER & GAMBLE COMPANY (US) | 2000-07-18 | — | — | US | claimed |
| US-5932604-A | Pharmaceutical compositions for the treatment of viral infections | THE PROCTER & GAMBLE COMPANY (US) | 1999-08-03 | — | — | US | claimed |
| US-5908855-A | ADMINISTERING FLUCONAZOLE WITH A POTENTIATOR (ESPECIALLY PROCODAZOLE). TREATMENT OF INFLUENZA. | THE PROCTER & GAMBLE COMPANY (US) | 1999-06-01 | — | — | US | claimed |
| US-5854231-A | Pharmaceutical composition for inhibiting the growth of cancers | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-29 | — | — | US | claimed |
| WO-1998022114-A1 | A METHOD FOR PROMOTING TISSUE REPAIR | DUMEX-ALPHARMA A/S (DK) | 1998-05-28 | — | — | WO | claimed |
| US-4662905-A | REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE | Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) | 1987-05-05 | — | — | US | claimed |